English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

A modern management of healthcare organizations e.g. tissue banks needs a resource based view (RBV) for an efficient stimulation of innovation, productivity and performance. High quality advanced therapy medicinal products (ATMPs) are expected to bring important health benefits therefore their production has to be performed in accordance with Good Manufacturing Practice (GMP). All aspects of pharmaceutical quality of ATMPs’ development, manufacturing, distribution, inspection and review processes must be strictly provided. Although there are no precisely defined criteria for quality control / evaluation methods of obtained ATMPs such criteria must be provided. Some of them in accordance to pharmacopoeia have been proposed in this chapter. As well as some explicit performance management and production regimes that fit into RBV and LEAN philosophy.

Resource-Based View of Laboratory Management: Tissue Bank ATMP Production as a Model